New research found that post-menopausal women had a higher risk of retinopathy, cardiovascular disease, neuropathy, falls, and moderate-to-severe depressive symptoms.
Recently, I was approached by a colleague who had seen a patient with type 1 diabetes using a glucagon-like peptide-1 receptor agonist in combination with basal bolus insulin to manage their glucose levels.
In a small randomized study, this dietary approach was associated with reduced insulin doses and treatment costs, without restricting calories or carbohydrates.